SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genstar GNT(formerly UroGen)-- an interesting speculation

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Lee who started this subject6/21/2001 11:23:59 AM
From: Paul Lee   of 100
 
Susan E. Atkins & Associates Adds Four San Diego Companies to Growing Roster; Biocept, CancerVax, GenStar and Santarus Join Growing List of Clientele


SAN DIEGO, June 21 /PRNewswire/ -- Susan E. Atkins & Associates, San Diego's largest investor and public relations firm focused on the Life Sciences, has announced the addition of four Companies located in San Diego County to its client roster. Continuing to maintain exponential growth in 2001, the firm will provide each company with strategic public and investor relations tools to help establish a corporate identity within its respective marketplace.

"Young and innovative Companies are changing the look of biotech today, and will change the way medicine is practiced for the future. We are enthusiastic about partnering with such bright and promising Companies," said Susan E. Atkins, President & CEO. "By employing the smartest people, Atkins & Associates hopes to help strategically position our clients within the increasingly competitive Life Sciences Industry."

These four Companies represent the breadth and depth of the biotechnology industry both at the local and national level:

-- Biocept, Inc. has developed a novel 3-D hydrogel for simple and cost

effective manufacturing of nucleic acid, protein, and whole cell

microarrays.

-- CancerVax Corporation is a privately held biotechnology company

dedicated to the discovery, development, and commercialization of

immunotherapeutic products for the treatment of cancer.

-- GenStar Therapeutics is a biopharmaceutical company developing

innovative gene therapy products for the treatment of serious medical

disorders including hemophilia A, prostate cancer and HIV.

-- Santarus is a specialty pharmaceutical company engaged in clinical

development and commercialization of drugs for the treatment of

gastrointestinal disease.

"San Diego is a major center for biotech and life sciences companies," said Atkins. "It is an ideal city to make a contribution as a leader in Bio Business."

With the above additions to its client roster, Atkins & Associates is now providing investor and public relations services to approximately 30 companies in the U.S. and Canada focused in the Life Sciences with annualized billings of almost $3 million.

About Atkins & Associates

Founded in 1999, Susan E. Atkins & Associates is a consulting firm serving public and pre-public companies within the Life Sciences industry by providing strategic counsel, pragmatic programs and projects in investor and public relations. With a client roster of national and international accounts, Atkins & Associates has significant experience with launching initial public offerings, corporate positioning and generating extensive awareness within the investor, business and media communities. For more information, call Atkins & Associates at (858) 860-0266 or visit the website at www.irpr.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext